TRIVASCULAR TECHNOLOGIES, INC. (TRIV) financial statements (2020 and earlier)

Company profile

Business Address 3910 BRICKWAY BOULEVARD
SANTA ROSA, CA 95403
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments79
Cash and cash equivalents33
Short-term investments46
Receivables7
Inventory, net of allowances, customer advances and progress billings9
Inventory9
Other undisclosed current assets3
Total current assets:97
Noncurrent Assets
Property, plant and equipment1
Intangible assets, net (including goodwill)9
Goodwill8
Intangible assets, net (excluding goodwill)1
Other noncurrent assets1
Total noncurrent assets:11
TOTAL ASSETS:109
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10
Accounts payable2
Accrued liabilities2
Employee-related liabilities7
Total current liabilities:10
Noncurrent Liabilities
Long-term debt and lease obligation55
Long-term debt, excluding current maturities55
Liabilities, other than long-term debt4
Other liabilities4
Total noncurrent liabilities:59
Total liabilities:69
Stockholders' equity
Stockholders' equity attributable to parent40
Common stock0
Additional paid in capital335
Accumulated other comprehensive loss(0)
Accumulated deficit(296)
Total stockholders' equity:40
TOTAL LIABILITIES AND EQUITY:109

Income statement (P&L) ($ in millions)

12/31/2014
Revenues
(Revenue, Net)
32
Cost of revenue
(Cost of Goods and Services Sold)
(15)
Other undisclosed gross profit1
Gross profit:18
Operating expenses(68)
Operating loss:(50)
Nonoperating income1
Other nonoperating income1
Interest and debt expense(8)
Other undisclosed income from continuing operations before equity method investments, income taxes0
Loss from continuing operations before income taxes:(57)
Income tax expense(0)
Net loss available to common stockholders, diluted:(57)

Comprehensive Income ($ in millions)

12/31/2014
Net loss:(57)
Other comprehensive loss(0)
Comprehensive loss, net of tax, attributable to parent:(58)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: